🇺🇸 FDA
Patent

US 8518890

Remedies for sex hormone dependent disease

granted A61KA61K31/56A61K38/08

Quick answer

US patent 8518890 (Remedies for sex hormone dependent disease) held by Takeda Pharmaceutical Company Limited expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/56, A61K38/08, A61K45/06, A61P